Paper34867367
Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma.
Manni L and 3 others. Front Pharmacol, 2021. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma. Papers, record 34867367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34867367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32547681 | Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. | World J Stem Cells | 2020 | https://conductscience.org/library/papers/32547681 | PubMed |
| 2 | 28710024 | Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy. | Brain Res Bull | 2017 | https://conductscience.org/library/papers/28710024 | PubMed |
| 3 | 24961518 | Neuroprotective role of nerve growth factor in hypoxic-ischemic brain injury. | Brain Sci | 2013 | https://conductscience.org/library/papers/24961518 | PubMed |
| 4 | 8548316 | Quantitative analysis of the olfactory pathway for drug delivery to the brain. | Brain Res | 1995 | https://conductscience.org/library/papers/8548316 | PubMed |
| 5 | 8025717 | Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus. | Eur J Neurosci | 1994 | https://conductscience.org/library/papers/8025717 | PubMed |
| 6 | 33358332 | Glucose metabolism: A link between traumatic brain injury and Alzheimer's disease. | Chin J Traumatol | 2021 | https://conductscience.org/library/papers/33358332 | PubMed |
| 7 | 22586589 | Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. | Diabetes | 2012 | https://conductscience.org/library/papers/22586589 | PubMed |
| 8 | 25676388 | Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. | Alzheimers Dement | 2015 | https://conductscience.org/library/papers/25676388 | PubMed |
| 9 | 21911655 | Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. | Arch Neurol | 2012 | https://conductscience.org/library/papers/21911655 | PubMed |
| 10 | 1540306 | Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). | J Neural Transm Park Dis Dement Sect | 1992 | https://conductscience.org/library/papers/1540306 | PubMed |
| 11 | 9701676 | Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. | Dement Geriatr Cogn Disord | 1998 | https://conductscience.org/library/papers/9701676 | PubMed |
| 12 | 11735609 | Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11735609 | PubMed |
| 13 | 30081536 | Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. | Pharmaceutics | 2018 | https://conductscience.org/library/papers/30081536 | PubMed |
| 14 | 11480588 | Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. | Arch Dermatol Res | 2001 | https://conductscience.org/library/papers/11480588 | PubMed |
| 15 | 6136314 | NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? | Brain Res | 1983 | https://conductscience.org/library/papers/6136314 | PubMed |
| 16 | 29582053 | Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial. | JAMA Neurol | 2018 | https://conductscience.org/library/papers/29582053 | PubMed |
| 17 | 15852017 | A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. | Nat Med | 2005 | https://conductscience.org/library/papers/15852017 | PubMed |
| 18 | 1849459 | The trk proto-oncogene encodes a receptor for nerve growth factor. | Cell | 1991 | https://conductscience.org/library/papers/1849459 | PubMed |
| 20 | 2411537 | Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. | EMBO J | 1985 | https://conductscience.org/library/papers/2411537 | PubMed |
| 21 | 33413694 | Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of Aβ and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice. | Acta Neuropathol Commun | 2021 | https://conductscience.org/library/papers/33413694 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42651149 | CHF6467 Exerts Neuroprotective Effects in the Rat Model of Acute Ischemic Stroke. | Brain Sci | 2026 | https://conductscience.org/library/papers/42651149 | PubMed |
| 42507332 | Disease mechanisms and translational barriers guide nanocarrier design for nose to brain delivery in Alzheimer's disease. | Discov Nano | 2026 | https://conductscience.org/library/papers/42507332 | PubMed |
| 42293152 | Application of neurodegenerative disease treatment strategies in tinnitus: mechanisms, translation, and prospects. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42293152 | PubMed |
| 42110196 | Toward an NGF-based therapy for Rett syndrome. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42110196 | PubMed |
| 42075845 | Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075845 | PubMed |
| 41471293 | Nerve Growth Factor in Diabetes Mellitus: Pathophysiological Mechanisms, Biomarkers and Therapeutic Opportunities. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471293 | PubMed |
| 40730695 | Intranasal delivery route for neurodegenerative diseases: recent insights and future directions. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/40730695 | PubMed |
| 40574087 | Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574087 | PubMed |
| 39901221 | Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/39901221 | PubMed |
| 39636503 | Filbertone-Induced Nrf2 Activation Ameliorates Neuronal Damage via Increasing BDNF Expression. | Neurochem Res | 2024 | https://conductscience.org/library/papers/39636503 | PubMed |
| 39598254 | Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39598254 | PubMed |
| 39455939 | Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches. | J Headache Pain | 2024 | https://conductscience.org/library/papers/39455939 | PubMed |
| 39300821 | Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice. | Brain | 2025 | https://conductscience.org/library/papers/39300821 | PubMed |
| 37789391 | Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome. | Biol Direct | 2023 | https://conductscience.org/library/papers/37789391 | PubMed |
| 37770684 | Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function. | Adv Tech Stand Neurosurg | 2023 | https://conductscience.org/library/papers/37770684 | PubMed |
| 36204836 | Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36204836 | PubMed |
| 35496270 | Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35496270 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34867367
GET https://conductscience.org/api/papers/v1/34867367/references?page=2